TABLE 4.
OR | CI | P-value | |
Age | 0.99 | 0.985–0.998 | 0.010 |
Mean METS-IR | 0.98 | 0.970–0.994 | 0.004 |
Diabetes | 0.88 | 0.692–1.122 | 0.304 |
Obesity | 1.10 | 0.894–1.351 | 0.368 |
LV mass index reduction | 2.57 | 2.056–3.216 | <0.0001 |
Beta blockers | 1.62 | 1.403–1.874 | <0.0001 |
Dihydropyridine Calcium channel blockers | 0.84 | 0.716–0.982 | 0.029 |
Antiplatelet therapy | 0.93 | 0.769–1.116 | 0.422 |
BP, blood pressure; CKD-EPI, chronic kidney disease epidemiology collaboration; LV, left ventricular; LV EF, left ventricular ejection fraction; MEEi, mechano-energetic efficiency indexed for myocardial mass.